These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 10411969
1. Quantity and origin of transplanted autologous blood cells are independent factors associated with speed of postransplant hematological reconstitution. Rogulj D, Batinić D, Nemet D, Petrovecki M. Croat Med J; 1999 Sep; 40(3):404-8. PubMed ID: 10411969 [Abstract] [Full Text] [Related]
2. Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma. Bhatia R, Van Heijzen K, Palmer A, Komiya A, Slovak ML, Chang KL, Fung H, Krishnan A, Molina A, Nademanee A, O'Donnell M, Popplewell L, Rodriguez R, Forman SJ, Bhatia S. J Clin Oncol; 2005 Sep 20; 23(27):6699-711. PubMed ID: 16170178 [Abstract] [Full Text] [Related]
3. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients. Bentley SA, Brecher ME, Powell E, Serody JS, Wiley JM, Shea TC. Bone Marrow Transplant; 1997 Mar 20; 19(6):557-63. PubMed ID: 9085735 [Abstract] [Full Text] [Related]
4. Factors affecting neutrophil recovery after autologous bone marrow-derived stem cell transplantation in patients with acute myeloid leukemia. Kozlowska-Skrzypczak M, Gil L, Komarnicki M. Transplant Proc; 2009 Nov 20; 41(9):3868-72. PubMed ID: 19917403 [Abstract] [Full Text] [Related]
5. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies. Carral A, de la Rubia J, Martín G, Martínez J, Sanz G, Jarque I, Sempere A, Soler MA, Marty ML, Sanz MA. Bone Marrow Transplant; 2002 May 20; 29(10):825-32. PubMed ID: 12058232 [Abstract] [Full Text] [Related]
6. Failure of bone marrow cryopreservation in chronic granulocytic leukemia: relation to excessive granulo-macrophagic progenitor pool. Douay L, Lopez M, Gorin NC, Nauman A, Giarratana MC, Laporte JP, Stachowiak J, Salmon C, Duhamel G. Int J Cell Cloning; 1986 Jul 20; 4(4):250-62. PubMed ID: 2875118 [Abstract] [Full Text] [Related]
7. An unusual pattern of hemopoietic reconstitution in patients with acute myeloid leukemia transplanted with autologous recovery phase peripheral blood. To LB, Haylock DN, Dyson PG, Thorp D, Roberts MM, Juttner CA. Bone Marrow Transplant; 1990 Aug 20; 6(2):109-14. PubMed ID: 1976398 [Abstract] [Full Text] [Related]
8. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies. Cao TM, Kusnierz-Glaz C, Valone F, Stockerl-Goldstein KE, Hu WW, Johnston L, Blume KG, Strober S, Negrin RS. Cancer; 2001 Jun 15; 91(12):2205-13. PubMed ID: 11413507 [Abstract] [Full Text] [Related]
9. [Collection of blood stem cells and therapeutic applications]. Reiffers J, Boiron JM, Marit G, Bouzgarrou R, Bernard P, David B, Foures C, Broustet A, Vezon G. Ann Med Interne (Paris); 1988 Jun 15; 139 Suppl 1():3-6. PubMed ID: 2907850 [Abstract] [Full Text] [Related]
10. [Autologous stem cell transplantation. From bone marrow to selected blood stem cells: 100 consecutive procedures at a single center]. Geisler CH, Simonsen AC, Mortensen BT, Christensen LD, Ersbøll JK, Andersen NS, Dickmeiss E, Hansen MM. Ugeskr Laeger; 1996 Apr 29; 158(18):2546-51. PubMed ID: 8686009 [Abstract] [Full Text] [Related]
11. Effect of pre-transplant cumulative doses of chemotherapeutic drugs on early and long-term hematological recovery after autologous bone-marrow transplantation for lymphoma. Martín A, Pérez-Simón JA, Caballero MD, López-Holgado N, Vázquez L, del Cañizo MC, San Miguel JF. Haematologica; 2005 Jan 29; 90(1):78-85. PubMed ID: 15642673 [Abstract] [Full Text] [Related]
12. [Kinetics of hematopoiesis after high-dose chemotherapy and autologous peripheral stem cell transplantation]. Mayer J, Korístek Z, Pospísil Z, Vásová I, Adam Z, Hájek R, Krejcí M, Král Z, Navrátil M, Vorlícek J, Bourková L, Matýsková M, Adler J, Vinklárková J, Klabusay M, Koutná I, Hoffová V, Schmitzová D, Janovská E. Cas Lek Cesk; 1999 Mar 15; 138(6):170-7. PubMed ID: 10510531 [Abstract] [Full Text] [Related]
13. [Autografts with peripheral blood stem cells]. Takaue Y, Ninomiya T. Rinsho Ketsueki; 1990 May 15; 31(5):609-13. PubMed ID: 1975630 [Abstract] [Full Text] [Related]
14. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Bierman PJ, Sweetenham JW, Loberiza FR, Taghipour G, Lazarus HM, Rizzo JD, Schmitz N, van Besien K, Vose JM, Horowitz M, Goldstone A, Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. J Clin Oncol; 2003 Oct 15; 21(20):3744-53. PubMed ID: 12963703 [Abstract] [Full Text] [Related]
15. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival. Dean R, Masci P, Pohlman B, Andresen S, Serafino S, Sobecks R, Kuczkowski E, Curtis J, Maciejewski J, Rybicki L, Kalaycio M, Hsi E, Theil K, Bolwell BJ. Bone Marrow Transplant; 2005 Dec 15; 36(12):1049-52. PubMed ID: 16247431 [Abstract] [Full Text] [Related]
16. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia. Kröger N, Zabelina T, Sonnenberg S, Krüger W, Renges H, Stute N, Finkenstein F, Mayer U, Holstein K, Fiedler W, Colberg H, Sonnen R, Kuse R, Braumann D, Metzner B, del Valle F, Erttmann R, Kabisch H, Zander AR. Bone Marrow Transplant; 2000 Oct 15; 26(7):711-6. PubMed ID: 11042650 [Abstract] [Full Text] [Related]
17. Myeloid progenitor cells (CFU-GM) predict engraftment kinetics in autologous transplantation in children. Emminger W, Emminger-Schmidmeier W, Höcker P, Hinterberger W, Gadner H. Bone Marrow Transplant; 1989 Jul 15; 4(4):415-20. PubMed ID: 2673462 [Abstract] [Full Text] [Related]
18. Secondary acute myeloid leukemia and myelodysplasia after autologous peripheral blood progenitor cell transplantation. Sevilla J, Rodríguez A, Hernández-Maraver D, de Bustos G, Aguado J, Ojeda E, Arrieta R, Hernández-Navarro F. Ann Hematol; 2002 Jan 15; 81(1):11-5. PubMed ID: 11807629 [Abstract] [Full Text] [Related]
19. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients. Kasow KA, Sims-Poston L, Eldridge P, Hale GA. Biol Blood Marrow Transplant; 2007 May 15; 13(5):608-14. PubMed ID: 17448921 [Abstract] [Full Text] [Related]
20. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies. Laurenti L, Chiusolo P, Garzia MG, Zini G, Sorà F, Piccirillo N, Piccioni P, Zollino M, Leone G, Sica S. Haematologica; 2002 Jan 15; 87(1):59-66. PubMed ID: 11801466 [Abstract] [Full Text] [Related] Page: [Next] [New Search]